Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghislain Bidaut

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Research|August 14, 2014
EFA6B antagonizes breast cancerJoséphine Zangari, Mariagrazia Partisani, François Bertucci, et al.
Clinical & Translational Immunology|August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
Frontiers in Immunology|February 28, 2017
A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cARTFrançoise Gondois-Rey, Antoine Chéret, Françoise Mallet, et al.
Frontiers in Immunology|January 3, 2022
Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid LeukemiaBerna Bou-Tayeh, Vladimir Laletin, Nassim Salem, et al.
Science Advances|December 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damageGeorgios Efthymiou, Eugénie Lohmann, Claudio Montenegro, et al.
Cell Reports|March 2, 2017
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT SignalingRita El Helou, Guillaume Pinna, Olivier Cabaud, et al.
JCI Insight|April 8, 2022
TET2 regulates immune tolerance in chronically activated mast cellsRiccardo Rigo, Rabie Chelbi, Julie Agopian, et al.
Cancer Research|October 4, 2017
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaMaria De Grandis, Florence Bardin, Cyril Fauriat, et al.
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinomaFabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaissi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|August 14, 2014
EFA6B antagonizes breast cancerJoséphine Zangari, Mariagrazia Partisani, François Bertucci, et al.
Clinical & Translational Immunology|August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
Frontiers in Immunology|February 28, 2017
A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cARTFrançoise Gondois-Rey, Antoine Chéret, Françoise Mallet, et al.
Frontiers in Immunology|January 3, 2022
Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid LeukemiaBerna Bou-Tayeh, Vladimir Laletin, Nassim Salem, et al.
Science Advances|December 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damageGeorgios Efthymiou, Eugénie Lohmann, Claudio Montenegro, et al.
Cell Reports|March 2, 2017
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT SignalingRita El Helou, Guillaume Pinna, Olivier Cabaud, et al.
JCI Insight|April 8, 2022
TET2 regulates immune tolerance in chronically activated mast cellsRiccardo Rigo, Rabie Chelbi, Julie Agopian, et al.
Cancer Research|October 4, 2017
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaMaria De Grandis, Florence Bardin, Cyril Fauriat, et al.
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinomaFabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaissi, et al.
Pageof 4